Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

169.37
Delayed Data
As of 4:14pm ET
 -2.50 / -1.45%
Today’s Change
160.07
Today|||52-Week Range
256.80
-19.35%
Year-to-Date
3 Drug/Biotech Stocks Up More Than 10% This Week
2:02am / Zacks.com - Paid Partner Content
Weekly Top Insider Buys Highlight for the Week of Dec. 8
Dec 10 / GuruFocus News - Paid Partner Content
John Paulson Reduces Synergy Pharmaceuticals After Heavy 3rd Quarter Health Care Sell...
Dec 12 / GuruFocus News - Paid Partner Content
3 Drug/Biotech Stocks Up More Than 10% This Week
Dec 08 / Zacks.com - Paid Partner Content
Roche Reports Positive Data from Tecentriq Combination Study
Dec 11 / Zacks.com - Paid Partner Content
Allergan Plc (AGN) Chairman, President and CEO Brent L Saunders Bought $757,804 of Sh...
Dec 07 / GuruFocus News - Paid Partner Content
Key Feature in Marketks
Dec 11 / TheStreet.com - Paid Partner Content
Quick News on Goldman, Allergan
Dec 07 / TheStreet.com - Paid Partner Content
Weekly CEO Buys Highlight
Dec 11 / GuruFocus News - Paid Partner Content
Outlook for Autodesk: Cramer's Top Takeaways
Dec 06 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close171.87
Today’s open171.00
Day’s range168.26 - 172.59
Volume129,517
Average volume (3 months)3,321,771
Market cap$57.2B
Data as of 4:14pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.25%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.16+0.46%
LLYEli Lilly and Co+1.19+1.37%
ABTAbbott Laboratories-0.64-1.15%
NVONovo Nordisk+0.08+0.14%
Data as of 4:14pm ET, 12/13/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$4.74
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts